Deprecated: mysql_pconnect(): The mysql extension is deprecated and will be removed in the future: use mysqli or PDO instead in /home/dcz25x0vfkvf/public_html/Connections/bscon1.php on line 9
Oncology

Oncology

Articles:
219 Mannose impairs tumour growth and enhances chemotherapy.
https://www.nature.com/articles/s41586-018-0729-3

218 Human-like hyperplastic prostate with low ZIP1 induced solely by Zn deficiency in rats.
http://www.pnas.org/content/115/47/E11091

217 CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma.
https://www.nejm.org/doi/full/10.1056/NEJMoa1807315

216 Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma.
https://www.nejm.org/doi/full/10.1056/NEJMoa1805762?query=featured_home

215 Enhanced detection of circulating tumor DNA by fragment size analysis.
http://stm.sciencemag.org/content/10/466/eaat4921

214 Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.
https://www.nejm.org/doi/full/10.1056/NEJMoa1809615

213 Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.
https://www.nejm.org/doi/full/10.1056/NEJMoa1802905

212 Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.
https://www.nejm.org/doi/full/10.1056/NEJMoa1805453

211 Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.
https://www.nejm.org/doi/full/10.1056/NEJMoa1805104

210 Prediction of acute myeloid leukaemia risk in healthy individuals.
https://www.nature.com/articles/s41586-018-0317-6

209 Cancer prevalence among flight attendants compared to the general population.
https://ehjournal.biomedcentral.com/articles/10.1186/s12940-018-0396-8

208 Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
https://www.nejm.org/doi/full/10.1056/NEJMoa1804710?query=featured_home

207 Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer.
https://www.nejm.org/doi/full/10.1056/NEJMoa1801005

206 Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.
https://www.nejm.org/doi/full/10.1056/NEJMoa1801946

205 Higher Lung Cancer Incidence in Young Women Than Young Men in the United States.
https://www.nejm.org/doi/full/10.1056/NEJMoa1715907

204 Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.
https://www.nejm.org/doi/full/10.1056/NEJMoa1716078

203 Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis.
http://stm.sciencemag.org/content/10/441/eaap8307

202 Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.
https://www.nejm.org/doi/full/10.1056/NEJMoa1802357

201 Analyses of genomes from 914 children, adolescents, and young adults provide a comprehensive resource of genomic alterations across a spectrum of common childhood cancers.
https://www.nature.com/articles/nature25480

200 Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.
http://www.nejm.org/doi/full/10.1056/NEJMoa1714678

199 Detection and localization of surgically resectable cancers with a multi-analyte blood test.
http://science.sciencemag.org/content/early/2018/01/17/science.aar3247

198 Contemporary Hormonal Contraception and the Risk of Breast Cancer.
http://www.nejm.org/doi/full/10.1056/NEJMoa1700732

197 Recovery of taste organs and sensory function after severe loss from Hedgehog/Smoothened inhibition with cancer drug sonidegib.
http://www.pnas.org/content/114/48/E10369.abstract

196 Lomustine and Bevacizumab in Progressive Glioblastoma.
http://www.nejm.org/doi/full/10.1056/NEJMoa1707358

195 Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer.
http://www.nejm.org/doi/full/10.1056/NEJMoa1709937

194 Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study.
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)31601-X/fulltext

193 Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32247-X/fulltext

192 Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.
http://www.nejm.org/doi/full/10.1056/NEJMoa1701769

191 Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
http://www.nejm.org/doi/full/10.1056/NEJMoa1709684

190 Obinutuzumab for the First-Line Treatment of Follicular Lymphoma.
http://www.nejm.org/doi/full/10.1056/NEJMoa1614598

189 Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.
http://www.nejm.org/doi/full/10.1056/NEJMoa1706450

188 Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer.
http://www.nejm.org/doi/full/10.1056/NEJMoa1701717

187 Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
http://www.nejm.org/doi/full/10.1056/NEJMoa1702900

186 Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.
http://www.nejm.org/doi/full/10.1056/NEJMoa1704174

185 Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers.
http://stm.sciencemag.org/content/9/398/eaah5583

184 An immunogenic personal neoantigen vaccine for patients with melanoma.
http://www.nature.com/nature/journal/v547/n7662/full/nature22991.html

183 Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis.
http://stm.sciencemag.org/content/9/384/eaai8504

182 Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma.
http://www.nejm.org/doi/full/10.1056/NEJMoa1611977

181 Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.
http://www.nejm.org/doi/full/10.1056/NEJMoa1613683

180 Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up.
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)30396-3/fulltext

Free Images for Presentation: sunipix SUNIPIX